These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12207613)

  • 1. Use of basiliximab as a cyclosporin-sparing agent in palmoplantar pustular psoriasis with myalgia as an adverse effect.
    Bell HK; Parslew RA
    Br J Dermatol; 2002 Sep; 147(3):606-7. PubMed ID: 12207613
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of severe psoriasis with basiliximab, an interleukin-2 receptor monoclonal antibody.
    Owen CM; Harrison PV
    Clin Exp Dermatol; 2000 May; 25(3):195-7. PubMed ID: 10844492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-TNF-alpha therapy in childhood pustular psoriasis.
    Pereira TM; Vieira AP; Fernandes JC; Antunes H; Basto AS
    Dermatology; 2006; 213(4):350-2. PubMed ID: 17135745
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of cyclosporin in a child with generalized pustular psoriasis.
    Alli N; Güngör E; Karakayali G; Lenk N; Artüz F
    Br J Dermatol; 1998 Oct; 139(4):754-5. PubMed ID: 9892934
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful treatment of severe generalized pustular psoriasis with basiliximab (interleukin-2 receptor blocker).
    Salim A; Emerson RM; Dalziel KL
    Br J Dermatol; 2000 Nov; 143(5):1121-2. PubMed ID: 11069550
    [No Abstract]   [Full Text] [Related]  

  • 6. Biological therapy.
    Roberts L
    Nurs Stand; 2004 Nov 17-23; 19(10):21. PubMed ID: 15612428
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of cyclosporin in a patient with hepatitis C and pustular psoriasis.
    Bomm L; Zimmermann CC; Souto R; Bressan A; Gripp A
    An Bras Dermatol; 2011; 86(4 Suppl 1):S193-5. PubMed ID: 22068808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trial.
    Reitamo S; Spuls P; Sassolas B; Lahfa M; Claudy A; Griffiths CE;
    Br J Dermatol; 2001 Sep; 145(3):438-45. PubMed ID: 11531834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of severe psoriasis with anti-CD25 monoclonal antibodies.
    Mrowietz U; Zhu K; Christophers E
    Arch Dermatol; 2000 May; 136(5):675-6. PubMed ID: 10815871
    [No Abstract]   [Full Text] [Related]  

  • 10. Failure of combination therapy with acitretin and cyclosporin A in 3 patients with erythrodermic psoriasis.
    Kuijpers AL; van Dooren-Greebe JV; van de Kerkhof PC
    Dermatology; 1997; 194(1):88-90. PubMed ID: 9031805
    [No Abstract]   [Full Text] [Related]  

  • 11. The Use of Methotrexate, Alone or in Combination With Other Therapies, for the Treatment of Palmoplantar Psoriasis.
    Wald JM; Klufas DM; Strober BE
    J Drugs Dermatol; 2015 Aug; 14(8):888-92. PubMed ID: 26267735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with the use of cyclosporin A in psoriasis. Results of a retrospective study.
    Ojeda R; Sánchez Regaña M; Massana J; Oliete R; Umbert P
    J Dermatolog Treat; 2005; 16(4):238-41. PubMed ID: 16249146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin in childhood psoriasis.
    Perrett CM; Ilchyshyn A; Berth-Jones J
    J Dermatolog Treat; 2003 Jun; 14(2):113-8. PubMed ID: 12775319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generalized pustular psoriasis following withdrawal of oral cyclosporin treatment for palmo-plantar pustulosis.
    De Silva BD; Benton EC; Tidman MJ
    Clin Exp Dermatol; 1999 Jan; 24(1):10-3. PubMed ID: 10233640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of basiliximab in pediatric renal transplant patients receiving cyclosporine, mycophenolate mofetil, and steroids.
    Offner G; Toenshoff B; Höcker B; Krauss M; Bulla M; Cochat P; Fehrenbach H; Fischer W; Foulard M; Hoppe B; Hoyer PF; Jungraithmayr TC; Klaus G; Latta K; Leichter H; Mihatsch MJ; Misselwitz J; Montoya C; Müller-Wiefel DE; Neuhaus TJ; Pape L; Querfeld U; Plank C; Schwarke D; Wygoda S; Zimmerhackl LB
    Transplantation; 2008 Nov; 86(9):1241-8. PubMed ID: 19005406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infant with generalized pustular psoriasis who responded to cyclosporin A therapy.
    Takahashi M; Takeuchi M; Matsunaga K
    J Dermatol; 2015 Sep; 42(9):911-3. PubMed ID: 26046589
    [No Abstract]   [Full Text] [Related]  

  • 17. Cancer-free survival of psoriasis patients treated with methotrexate and cyclosporine combination.
    Aydin F; Yuksel EP; Senturk N; Canturk T; Turanli AY
    Cutan Ocul Toxicol; 2014 Sep; 33(3):181-3. PubMed ID: 23944659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced-exposure cyclosporine is safe and efficacious in de novo renal transplant recipients treated with enteric-coated mycophenolic acid and basiliximab.
    Budde K; Bosmans JL; Sennesael J; Zeier M; Pisarski P; Schütz M; Fischer W; Neumayer HH; Glander P
    Clin Nephrol; 2007 Mar; 67(3):164-75. PubMed ID: 17390741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pustular Psoriasis of Pregnancy Successfully Treated With Cyclosporine.
    Bangale-Daflapurkar S; Danve A
    Am J Ther; 2016; 23(5):e1250-2. PubMed ID: 26360534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palmoplantar pustular psoriasis: successful therapy with efalizumab after non-response to infliximab.
    Wozel G; Vitez L
    Acta Derm Venereol; 2008; 88(2):169-70. PubMed ID: 18311451
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.